rs3738198 — SLC30A1 ZnT1 variant

Intronic variant in the ZnT1 zinc efflux transporter gene; the minor C allele (plus-strand) tags a regulatory haplotype that may modestly reduce SLC30A1 expression or function, potentially lowering the efficiency of basolateral zinc export from intestinal enterocytes into the portal circulation and impairing the zinc-flux capacity of macrophages and other cells that depend on ZnT1 for intracellular zinc homeostasis

See your personal result for SLC30A1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

SLC30A1 rs3738198 — An Intronic Variant in the Primary Zinc Export Gateway

Every milligram of dietary zinc that enters systemic circulation must first cross the basolateral membrane of an intestinal enterocyte. Only one protein manages that crossing at scale: ZnT111 ZnT1
Zinc Transporter 1, the product of SLC30A1 on chromosome 1q32.3; ubiquitously expressed, plasma-membrane localised, the dominant zinc efflux pump in most mammalian cell types. Without functional ZnT1, dietary zinc accumulates inside the enterocyte and never reaches the portal vein. The knockout phenotype in mice is lethal within weeks — a fact that underscores just how central this single protein is to whole-body zinc supply.

rs3738198 is an intronic variant (GRCh38 chromosome 1, position 211,576,392; G>C on the plus strand, C>G on the coding minus strand) lying within an intron of SLC30A1. The minor C allele (plus-strand) is present in roughly 13–15% of all chromosomes globally, with higher frequency in African (~22%) and East Asian (~20%) populations than in Europeans (~11%). No clinical significance entry exists in ClinVar, and no published study has directly tested this rsid in a phenotypic association study. Its biological plausibility rests on the gene's established, essential role in zinc homeostasis and the observation that SLC30A1 expression is exquisitely sensitive to regulatory inputs — making intronic regulatory variants a plausible source of inter-individual variability in zinc absorption efficiency.

The Mechanism

SLC30A1 encodes a homodimeric six-transmembrane-helix zinc transporter that coordinates zinc at two binding sites (Z1 and Z2) within the transmembrane core. Mutations at the Z2 site produce the most robust reductions in zinc export capacity, consistent with Z2 being the primary zinc-translocation interface22 Mutations at the Z2 site produce the most robust reductions in zinc export capacity, consistent with Z2 being the primary zinc-translocation interface. The protein is localised to the basolateral membrane of intestinal epithelial cells, the plasma and lysosomal membranes of macrophages, and the neuronal plasma membrane — wherever cells need to expel excess cytosolic zinc.

Gene expression is driven through two metal-response element (MRE) sequences in the SLC30A1 promoter. When intracellular zinc rises, the transcription factor MTF-133 MTF-1
Metal-regulatory transcription factor 1; the master zinc sensor that activates metallothionein and ZnT1 genes in response to cytosolic zinc elevation translocates to the nucleus and induces ZnT1 mRNA up to 12-fold within 3 hours. Conversely, dietary zinc deficiency down-regulates ZnT1 expression by ~40% to help cells retain zinc. An intronic variant like rs3738198 could influence this regulatory dynamic by altering splicing efficiency, intronic enhancer activity, or chromatin accessibility near MTF-1 binding sites — mechanisms that have not been specifically studied at this locus but are well-established for intronic variants at other transporter genes.

The Evidence

Gene essentiality: The most direct evidence for ZnT1's importance comes from mouse models. Ruaud et al. (2024)44 Ruaud et al. (2024) showed that inducible intestinal-specific Slc30a1 knockout mice die within two weeks of gene deletion, with serum zinc crashing, intestinal barrier disruption, and massive inflammatory activation. Systemic zinc injection fully rescued all animals. This establishes intestinal SLC30A1 as the non-redundant gate for dietary zinc delivery.

Somatic mutations and ion selectivity: A 2023 Nature Genetics study by Nanba et al.55 Nanba et al. identified recurrent in-frame deletions at the His43/Asp47 zinc-binding site in SLC30A1 as the driver of aldosterone-producing adenomas through gain-of-function sodium influx. While these are somatic coding mutations — distinct from the germline intronic rs3738198 — they demonstrate that even small structural changes near the zinc-binding site substantially alter ion transport selectivity, and that ZnT1 function is exquisitely sensitive to perturbation.

Immune zinc mobilisation: Stocks et al. (2021)66 Stocks et al. (2021) showed that LPS-induced SLC30A1 in human macrophages delivers zinc into vesicular compartments around intracellular bacteria, creating a toxic zinc microenvironment that limits bacterial growth. This links ZnT1 not only to nutritional zinc supply but to the front line of innate immune defence.

Direct rs3738198 evidence: No published study has tested this specific intronic rsid for phenotypic association with serum zinc, immune function, or other outcomes. The evidence level for this variant specifically is accordingly emerging — biologically plausible, mechanistically grounded, but lacking direct human genetic evidence for phenotypic effect.

Practical Actions

Because rs3738198 is an intronic variant with no direct phenotypic evidence, practical guidance is drawn from the broader biology of ZnT1 and zinc homeostasis rather than from genotype-specific outcome data. The core idea is that anyone with a haplotype that may modestly reduce basolateral zinc export efficiency should ensure their dietary zinc supply is robust, use forms with higher bioavailability, and monitor for functional zinc inadequacy — recognising that the degree of risk from this specific variant alone is uncertain.

Zinc bioavailability from food varies dramatically: meat-source zinc (with animal proteins that enhance absorption) reaches 25–40% absorption efficiency, while phytate- rich plant sources (legumes, wholegrains) yield 10–15%. For someone whose intestinal ZnT1 may be at reduced capacity, optimising the bioavailability of dietary zinc provides a margin of safety without requiring supplementation.

Interactions

With SLC30A8 (ZnT8): SLC30A8 controls zinc secretion into insulin vesicles in pancreatic beta cells. While ZnT1 and ZnT8 operate in different tissues and contexts, their combined genetic load is relevant to understanding whole-body zinc distribution. Individuals carrying modestly reduced function in both a systemic zinc exporter (ZnT1/SLC30A1) and a tissue-specific zinc sequestrant (ZnT8/SLC30A8) may have atypical zinc partitioning between compartments.

With dietary zinc and phytate: The zinc-sensing MTF-1/ZnT1 axis is responsive to dietary zinc status. High-phytate diets that reduce zinc absorption will exacerbate any baseline reduction in ZnT1 export capacity, while zinc-adequate diets from high-bioavailability sources compensate. This gene-diet interaction is the primary lever available to C-allele carriers at this locus.

Nutrient Interactions

zinc altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal

Common ZnT1 genotype — no known effect on zinc homeostasis

You carry two copies of the common G allele at rs3738198 (plus-strand notation; coding-strand C at the GRCh38 reference position). This is the most frequent genotype globally, present in approximately 74% of people. No alteration to SLC30A1 gene expression or ZnT1 transporter function has been associated with this genotype. Your ZnT1-mediated zinc export pathway is expected to operate within the normal population range.

CG Intermediate

One C allele — possible modest effect on ZnT1 regulation

SLC30A1 is regulated by the metal-response element transcription factor MTF-1, which drives ZnT1 mRNA up to 12-fold in response to rising intracellular zinc and down-regulates it when zinc is scarce. Intronic variants can modulate this regulatory response by altering chromatin accessibility, transcription factor binding within intronic enhancers, or splicing of the primary transcript. The rs3738198 C allele sits in intron 1 of SLC30A1 and may influence one of these regulatory layers — but this has not been experimentally tested.

The evidence that SLC30A1 expression level matters quantitatively comes from dietary depletion studies: a 40% reduction in ZnT1 protein in zinc-deficient animals was sufficient to produce measurable changes in cellular zinc retention. Whether the C allele at rs3738198 produces a comparable regulatory change in humans is not established.

CC Decreased

Two C alleles — the minor homozygous genotype; uncertain but plausible reduction in ZnT1 regulatory capacity

ZnT1's role in zinc homeostasis operates through two functionally distinct pathways. In the intestine, it exports absorbed zinc across the basolateral membrane into the portal vein — the sole route for dietary zinc to enter systemic circulation at scale. In immune cells, particularly macrophages, ZnT1 is rapidly up-regulated by bacterial signals (LPS, cytokines) to deliver zinc into vesicular compartments surrounding intracellular pathogens. Both functions depend on adequate ZnT1 expression and activity.

An intronic variant that reduces SLC30A1 transcript abundance or splicing efficiency could therefore affect two distinct systems: nutritional zinc delivery and innate immune zinc toxicity. The former would manifest as marginally lower serum zinc at a given dietary intake; the latter might contribute to subtly impaired bacterial clearance under infection conditions — though at the effect sizes typical of common intronic variants, any such effect is likely small. CC homozygotes represent the additive extreme of any such effect.

Functional zinc adequacy can be estimated through plasma/serum zinc (normal range 70–110 µg/dL), though this biomarker is insensitive to mild deficiency. The erythrocyte zinc and alkaline phosphatase activity are complementary biomarkers that may detect functional zinc limitation even when serum zinc is normal.